Extension Letter Amendment to Consulting and Scientific Advisory Board Agreement between AVEO Pharmaceuticals, Inc. and Raju Kucherlapati, PhD
AVEO Pharmaceuticals, Inc. and Dr. Raju Kucherlapati have agreed to extend the term of their Consulting and Scientific Advisory Board Agreement. The consultation period, originally set to end earlier, will now continue through December 31, 2013, unless terminated sooner as specified in the agreement. All other terms and obligations of the original agreement remain unchanged.
Exhibit 10.23
 | AVEO Pharmaceuticals, Inc. 75 Sidney Street Cambridge, MA 02139
www.aveopharma.com |
October 31, 2011
Raju Kucherlapati, PhD
6 Wildflower Lane
Weston, MA 02493
Re: Consulting and Scientific Advisory Board Agreement by and between Raju Kucherlapati, PhD and AVEO Pharmaceuticals, Inc. effective as of January 1, 2010 (the “Agreement”)
Dear Dr. Kucherlapati,
It is hereby agreed that Section 2 of the Agreement shall be amended to extend the Consultation Period through and including December 31, 2013 unless sooner terminated in accordance with Section 11 of the Agreement. All other terms and obligations under the Agreement shall remain the same.
| Sincerely, |
| /s/ Murray O. Robinson |
| Murray O. Robinson, PhD |
| Senior Vice President, Translational Research |
| Chair of the Scientific Advisory Board |
| Agreed and Acknowledged: | ||||||
| /s/ Raju Kucherlapati | November 3, 2011 | |||||
| Raju Kucherlapati, PhD | Date | |||||
